Difference between revisions of "Template:Drugs for functional gastrointestinal disorders"
Jump to navigation
Jump to search
imported>DePiep (rm Mednav index templates. See talk (via AWB script)) |
imported>Anypodetos |
||
(6 intermediate revisions by 4 users not shown) | |||
Line 6: | Line 6: | ||
| group1 = Drugs for<br/> [[functional bowel disorder|functional<br/> bowel disorders]] | | group1 = Drugs for<br/> [[functional bowel disorder|functional<br/> bowel disorders]] | ||
− | | list1 = {{Navbox subgroup | + | | list1 = {{Navbox|subgroup |
| group1 = [[Muscarinic antagonist|Antimuscarinic]]s | | group1 = [[Muscarinic antagonist|Antimuscarinic]]s | ||
− | | list1 = {{Navbox subgroup | + | | list1 = {{Navbox|subgroup |
| group1 = Tertiary<br/> amino group | | group1 = Tertiary<br/> amino group | ||
Line 60: | Line 60: | ||
* ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonists]]'' | * ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonists]]'' | ||
**[[Mosapride]] | **[[Mosapride]] | ||
− | |||
− | |||
| group4 = Other | | group4 = Other | ||
Line 74: | Line 72: | ||
* [[Idanpramine]] | * [[Idanpramine]] | ||
* [[Isometheptene]] | * [[Isometheptene]] | ||
+ | * [[Mentha piperita]] | ||
* [[Phloroglucinol]] | * [[Phloroglucinol]] | ||
− | * [[Pinaverium]] | + | * [[Pinaverium bromide]] |
* [[Proxazole]] | * [[Proxazole]] | ||
* [[Silicones]] | * [[Silicones]] | ||
Line 86: | Line 85: | ||
| group2 = [[Atropa belladonna|Belladonna]]<br/> and derivatives<br/> ([[Muscarinic antagonist|antimuscarinic]]s) | | group2 = [[Atropa belladonna|Belladonna]]<br/> and derivatives<br/> ([[Muscarinic antagonist|antimuscarinic]]s) | ||
| list2 = | | list2 = | ||
− | * '' | + | * ''Tertiary amines:'' [[Atropine]] |
* [[Hyoscyamine]] | * [[Hyoscyamine]] | ||
− | *'' | + | *''Quaternary ammonium compounds:'' |
**[[Hyoscine hydrobromide|Scopolamine]] | **[[Hyoscine hydrobromide|Scopolamine]] | ||
** [[Butylscopolamine]] | ** [[Butylscopolamine]] | ||
** [[Methylscopolamine bromide|Methylscopolamine]] | ** [[Methylscopolamine bromide|Methylscopolamine]] | ||
* [[Methylatropine]] | * [[Methylatropine]] | ||
− | * [[Fentonium]] | + | * [[Fentonium bromide]] |
* [[Cimetropium bromide]] | * [[Cimetropium bromide]] | ||
| group3 = [[Prokinetic|Propulsive]]s | | group3 = [[Prokinetic|Propulsive]]s | ||
| list3 = | | list3 = | ||
− | * ''[[dopamine antagonist| | + | * ''[[dopamine antagonist|Primarily dopamine antagonists]]'' |
** [[Metoclopramide]]/[[Bromopride]] | ** [[Metoclopramide]]/[[Bromopride]] | ||
** [[Clebopride]] | ** [[Clebopride]] |
Latest revision as of 14:08, 3 January 2021
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Drugs for functional gastrointestinal disorders|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Drugs for functional gastrointestinal disorders|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Drugs for functional gastrointestinal disorders|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.